Skip to main content

Table 5 Univariate analyses of covariance between treatment status at baseline (T0)

From: Psychometric properties of the quality of life in short statured youth (QoLISSY) questionnaire within the course of growth hormone treatment

 

Treated (IGHD/SGA)

Untreated (ISS)

 

Patient-reports

M (SD) (N = 40)

M (SD) (N = 22)

F

p

Ŋp2

Physical

48.33 (28.00)

69.88 (17.86)

8.44

.005

.12

Social

46.99 (29.03)

64.85 (18.86)

4.72

.03

.07

Emotional

47.35 (25.13)

65.76 (26.67)

5.76

.02

.09

Coping

62.50 (21.40)

62.38 (24.30)

.01

.92

.00

Beliefs

43.28 (29.70)

61.36 (32.76)

3.57

.06

.05

Total Score a

47.56 (25.74)

66.83 (18.04)

7.445

.008

.11

Parents-reports

M (SD) (N = 99)

M (SD) (N = 28)

F

p

Ŋp2

Physical

47.84 (25.97)

65.47 (24.05)

8.91

.003

.06

Social

47.40 (24.79)

58.72 (23.79)

4.59

.03

.03

Emotional

48.42 (24.63)

57.86 (26.41)

4.69

.03

.03

Coping

49.10 (16.99)

58.22 (19.56)

3.95

.04

.03

Beliefs

52.52 (29.25)

58.25 (33.29)

1.39

.24

.01

Future

53.93 (30.21)

68.57 (26.62)

8.12

.005

.06

Effects on parents

49.61 (22.34)

56.69 (22.05)

1.48

.22

.01

Total Score a

49.91 (23.54)

61.50 (22.58)

7.70

.006

.05

  1. Note: M = Mean, SD = Standard deviation, F=F-value, p = P-value, Ŋp2 = partial eta square, IGHD = idiopathic growth hormone deficiency, SGA = short for gestational age, ISS = idiopathic short stature
  2. Children’s age and height deviation group were included as covariates
  3. a sum of the scales physical, social, emotional